# Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults

> **NCT04636697** · PHASE2,PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Medicago** · enrollment: 30918 (estimated)

## Conditions studied

- SARS-CoV-2 Infection

## Interventions

- **DRUG:** Intramuscular injection
- **BIOLOGICAL:** Intramuscular vaccine

## Key facts

- **NCT ID:** NCT04636697
- **Lead sponsor:** Medicago
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-11-19
- **Primary completion:** 2021-08-25
- **Final completion:** 2022-04-30
- **Target enrollment:** 30918 (ESTIMATED)
- **Last updated:** 2022-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04636697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04636697, "Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04636697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*